Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer.
10.3346/jkms.2016.31.10.1586
- Author:
Shu Qian WANG
1
;
Yu LIU
;
Min Ya YAO
;
Jing JIN
Author Information
1. General Surgery Department, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Publication Type:Original Article
- Keywords:
eIF3a;
Proliferation;
Migration;
Invasion;
Pancreatic Ductal Adenocarcinoma
- MeSH:
Adenocarcinoma;
Animals;
Cell Movement;
Cell Proliferation*;
Mice;
Neoplasm Metastasis;
Neoplasm Staging;
Pancreatic Ducts;
Pancreatic Neoplasms*;
Peptide Initiation Factors*;
RNA, Small Interfering;
Wounds and Injuries
- From:Journal of Korean Medical Science
2016;31(10):1586-1594
- CountryRepublic of Korea
- Language:English
-
Abstract:
Identifying a target molecule that is crucially involved in pancreatic tumor growth and metastasis is necessary in developing an effective treatment. The study aimed to investigate the role of the eukaryotic translation initiation factor 3a (eIF3a) in the cell proliferation and motility in pancreatic cancer. Our data showed that the expression of eIF3a was upregulated in pancreatic ductal adenocarcinoma as compared with its expression in normal pancreatic tissues. Knockdown of eIF3a by a specific shRNA caused significant decreases in cell proliferation and clonogenic abilities in pancreatic cancer SW1990 and Capan-1 cells. Consistently, the pancreatic cancer cell growth rates were also impaired in xenotransplanted mice. Moreover, wound-healing assay showed that depletion of eIF3a significantly slowed down the wound recovery processes in SW1990 and Capan-1 cells. Transwell migration and invasion assays further showed that cell migration and invasion abilities were significantly inhibited by knockdown of eIF3a in SW1990 and Capan-1 cells. Statistical analysis of eIF3a expression in 140 cases of pancreatic ductal adenocarcinoma samples revealed that eIF3a expression was significantly associated with tumor metastasis and TNM staging. These analyses suggest that eIF3a contributes to cell proliferation and motility in pancreatic ductal adenocarcinoma.
